EUVIMEDEUVIMED entdecken
Crossref

CD56bright NK cell expansion correlated with EBV reactivation control post allogeneic hematopoietic stem cell transplantation

Xie Juan, Zeying Fan, Xunhong Cao, Yi-Yang Ding, Huixin Liu, Qian-Nan Shang, Xiaosu Zhao, Yingjun Chang, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang und 1 weitere

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-05827-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Xie Juan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Ke…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Hematopoietic Stem Cell Transplantation, CD56 Antigen, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science, Technology& Innovation Project of Xiongan New area, Peking University People's Hospital Research and Development Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells are equipped with anti-Epstein-Barr virus (EBV) function, however, whether EBV infection will affect NK cells reconstitution after allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains unclear. To identify the characteristics of NK cells, we prospectively enrolled 11 patients who occurred EBV reactivation post allo-HSCT and 11 patients without EBV infection as control. We found that that EBV infection induced the expansion of CD56bright and NKG2A+KIR- NK subsets,and decreased the cytotoxicity function of NK cells. The frequency of NKG2A+KIR- NK cells were higher in patients who progressed into post-transplant lymphoproliferative disorder (PTLD) than EBV viremia patients, which also correlated with decreased proliferation and cytotoxic function. By screening the activation receptors of NK cells, we found the DNAM-1+CD56bright NK cells is significantly increased after EBV stimulation, further we demonstrated that DNAM-1 is essential for EBV induced NK cells activation as the cytokine release against EBV-transformed lymphoblastoid cell lines(EBV-LCLs) of CD56bright NK cells were significantly decreased after DNAM-1 blockade. NK cells infusion suppressed the progression of EBV-related tumor mice model. A prospective cohort indicated that old donor age was an independent risk factor for EBV infection. Rapid CD56bri expansion and high expression of DNAM-1 on CD56bri NK cells in response to EBV reactivation correlated with rapid EBV clearance post allo-HSCT in patients with younger donors. In summary, our data showed that high expression of DNAM-1 receptors on NK cell may participate protective CD56bri NK cells response to EBV infection after allo-HSCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalHematopoietic Stem Cell TransplantationCD56 AntigenEpstein-Barr Virus InfectionsHerpesvirus 4, HumanVirus ActivationHumansFemaleMaleAdultMiddle AgedAnimalsMiceProspective StudiesAdolescentYoung AdultTransplantation, HomologousAllograftsAntigens, Differentiation, T-LymphocyteT Lineage-Specific Activation Antigen 1

Stichwörter der Autor:innen

Allo-HSCTCD56bright NKDNAM-1EBV reactivation

Substanzen

CD56 AntigenNCAM1 protein, humanT Lineage-Specific Activation Antigen 1Antigens, Differentiation, T-Lymphocyte

Autor:innen und Institutionen

  • Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, Chin…
  • Collaborative Innovation Center of Hematology, Beijing, China. zhao_xy@bjmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Science, Technology& Innovation Project of Xiongan New area
  • Peking University People's Hospital Research and Development Funds
  • National Key Research and Development Program of China
  • Beijing Nova Program
  • Peking University People’s Hospital Research and Development Funds

Zitieren

APA

Juan, X., Fan, Z., Cao, X., Ding, Y. Y., Liu, H., Shang, Q. N., Zhao, X., Chang, Y., Wang, Y., Xu, L., Zhang, X., Huang, X., & Zhao, X. (2024). CD56bright NK cell expansion correlated with EBV reactivation control post allogeneic hematopoietic stem cell transplantation. Annals of Hematology. https://doi.org/10.1007/s00277-024-05827-4

Vancouver

Juan X, Fan Z, Cao X, Ding YY, Liu H, Shang QN, et al. CD56bright NK cell expansion correlated with EBV reactivation control post allogeneic hematopoietic stem cell transplantation. Annals of Hematology. 2024. doi:10.1007/s00277-024-05827-4

BibTeX
@article{Juan2024,
  author = {Juan, Xie and Fan, Zeying and Cao, Xunhong and Ding, Yi-Yang and Liu, Huixin and Shang, Qian-Nan and Zhao, Xiaosu and Chang, Yingjun and Wang, Yu and Xu, Lanping and Zhang, Xiaohui and Huang, Xiaojun and Zhao, Xiangyu},
  title = {CD56bright NK cell expansion correlated with EBV reactivation control post allogeneic hematopoietic stem cell transplantation},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-05827-4}
}
Kostenlos starten →